Evaluating a new implant system for knee cartilage degeneration
Official title: Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration
Run by ZKR Orthopedics Inc · NCT06423300 · Data updated 2026-11-12
This study is testing a new knee implant to see if it can help people with cartilage damage feel less pain and move better compared to a standard surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years to 65 Years |
| Sex | All |
| Enrollment | 245 (estimated) |
| Sponsor | ZKR Orthopedics Inc Industry-sponsored |
| Locations | 5 sites (La Mesa, California and 4 other locations) |
| Status | Recruiting |
| Started | June 19, 2024 |
| Main results expected | September 2027 |
| Study ends | September 2031 |
| Registry record updated | December 11, 2025 |
| Trial ID | NCT06423300 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 22 to 65 with significant anterior knee pain due to patellofemoral cartilage degeneration.
✕Probably not a fit
Patients with less severe cartilage degeneration or significant issues in the opposite knee may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial compares the outcomes of patients with patellofemoral cartilage degeneration treated with the LIFT Implant System against those undergoing Tibial Tubercle Osteotomy (TTO). It is a prospective, non-randomized, dual-arm, multi-center study designed to assess the effectiveness of the LIFT Implant in alleviating knee pain and improving function. Participants will be monitored for clinical outcomes over a specified period to determine the advantages of the LIFT system over traditional surgical methods.
Why it matters
Potential benefit: If successful, this study could provide a less invasive treatment option for patients suffering from knee pain due to cartilage degeneration.
How similar studies have gone: Other studies have shown promising results with similar approaches, but the LIFT Implant System is a novel intervention in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients age 22 to 65 years at time of screening 2. Anterior knee pain due to patellofemoral cartilage degeneration (PCD) with an Modified Outerbridge score of ≥3 as assessed by an MRI on the study knee 3. Body Mass Index (BMI) of ≤ 35 4. Weight \< 300 lbs 5. Anterior Knee Pain Score (AKPS) of ≤ 70 (0-100 scale) 6. Visual Analog Score (VAS) of ≥ 40 (0-100 scale) 7. Failure of at least 6 months of non-surgical treatment defined as at least one of the treatments (e.g. rest, bracing, physical therapy, targeted exercise, use of NSAIDs, activity level reduction or Confidential ZKR Orthopedics, CIP 0001 Page 11 of 55 Protocol Version: 1.0, 04JAN2024 modification, etc.) per AAOS Treatment of Osteoarthritis of the Knee; Evidence based guideline 3rd Edition 2021 Exclusion Criteria: 1. PCD with an Modified Outerbridge Score of 2 or less at the study knee 2. Clinical symptoms of the contralateral knee that preclude activities of daily living, stair climbing, stair descending, or require the use of an assist device 3. History of patella dislocation or instability 4. Patella alta or patella baja 5. Known TT-TG distance \>20mm 6. Patients requiring simultaneous cartilage grafting procedure, cartilage transplantation, or bone marrow stimulation 7. Previous repair of a torn patellar tendon 8. Prior TTO procedure or knee joint replacement (total or partial) of the study knee 9. Joint modifying surgery (e.g., ligament reconstruction, meniscus repair, cartilage transplantation, microfracture, etc.) in the study knee within 6 months prior to planned index procedure date 10. Arthroscopic surgeries in the study knee for joint lavage, meniscectomy, chondral debridement, and loose body removal within 3 months prior to planned index procedure 11. Active infection, sepsis, osteomyelitis or history of septic arthritis in any joint 12. Rheumatoid arthritis, other forms of inflammatory joint disease or autoimmune disorder 13. History of avascular necrosis of any bone 14. History of symptomatic patellar tendonitis of intrasubstance tear 15. Insufficiency of the cruciate, collateral ligaments, or tendon which would preclude stability of the LIFT System 16. Pathologic ligamentous injury (Lachman \> 1) or meniscus tearing 17. Clinical symptoms of the femoral-tibial joint of the study knee that preclude activities of daily living, stair climbing, stair descending, or requires the use of an assist device 18. Evidence (MRI, arthroscopy, etc.) of Modified Outerbridge Grade 4 degenerative arthritis in the femoral-tibial joint of the study knee that potentially explains patient symptoms
Where it's running
-
Horizon Clinical Research
La Mesa, California, United States Recruiting -
Hospital for Special Surgery
New York, New York, United States Recruiting -
NYU Langone Health
New York, New York, United States Recruiting -
Ohio State University - Jameson Crane Sports Medicine Institute
Columbus, Ohio, United States Recruiting -
Oregon Health and Science University
Portland, Oregon, United States Recruiting
Study contacts
- Study coordinator: Sharon Branch
- Email: clinadmin@zkrorthopedics.com
- Phone: 9543033777
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FDG PET/MRI to Find Painful Inflammation in the Patellofemoral Joint
This study tests whether FDG PET/MRI can locate inflammation causing knee pain in people with patellofemoral joint osteoarthritis.
-
Engineered cartilage grafts for treating knee osteoarthritis
This study is testing a new cartilage treatment made from nasal cells to see if it helps people with knee osteoarthritis feel better compared to standard care options.
-
Treatment for knee osteoarthritis using engineered cartilage from nasal cells
This study is testing whether a new cartilage treatment made from nasal cells can help people with knee osteoarthritis feel less pain and improve their knee function compared to standard injections.
-
Comparing PRP and HA injections for knee osteoarthritis
This study is testing whether injections of platelet-rich plasma or hyaluronic acid can help people with knee osteoarthritis feel better over two years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.